Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

Webinar Wednesday: Mariano Severgnini from Dana-Farber Cancer Institute

Soluble Biomarker Detection in Cancer Patients Treated with Immunotherapies using xMAP® Technology

For our fourth Webinar Wednesday blog, we’re featuring a talk from Mariano Severgnini, who is the lead scientist at the Immune Assessment Lab (IAL) in the Center for Immuno-Oncology (CIO) at Dana-Farber Cancer Institute. The IAL serves as the focal point for immunotherapy clinical trials by providing expertise in sample banking and processing as well as assay development and execution for immune monitoring.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

RT @IDSAInfo: An antibiotic post-prescription audit and review program was successfully implemented in four community hospitals, according…
h J R
Seeking to reveal the mechanisms of inflammatory response during extreme exercise, researchers at @UNTsocial Applie…
h J R
"People hear the talks, they hear about the technology, they ask us about the possibilities & they are really excit…
h J R

Latest News

February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference

January 24
Luminex Corporation Declares First Quarter Cash Dividend

January 7
Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017

December 13
Luminex Corporation Declares Fourth Quarter Cash Dividend

November 14
Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference


Bio-Europe Spring Meeting
12-14 March
Amsterdam, Netherlands

14-17 March
Wurzburg, Germany

27-28 March
Papendaal, Netherlands

10-13 April
Munich, Germany

12-14 April
Erfurt, Germany